Connect with us
Rui Santos Ivo, president of the National Authority for Medicines and Health Products IP (Infarmed), was elected president of the Management Board of the European Medicines Agency...
The European Commission has responded to a request for clarification from CannaReporter® on the recent decision by Infarmed IP to withdraw several cosmetic products containing cannabidiol from the market...
Last week, CannaReporter® requested information from Infarmed – National Authority for Medicines and Health Products IP, after the withdrawal of some cosmetics with...
Infarmed – National Authority for Medicines and Health Products, IP approved two new ACMs (Authorization for Placing on the Market) for preparations based on...
Infarmed gave the green light to three new cannabis derivatives in Portugal, which are now available in pharmacies and are part of the arsenal of options...
Portugal remains well positioned to be one of the main producers of medicinal cannabis in the world. There are currently 42 companies with Infarmed IP licenses to...
Portugal has already exported more than 5.4 tons of cannabis in 2023, mainly to Germany, Poland and Australia, but doctors continue to prescribe very little in...
Blossom Pharma received GMP I and GMP II licenses from Infarmed – National Authority for Medicines and Health Products, IP to manufacture medicinal cannabis. A...
Infarmed – National Authority for Medicines and Health Products IP today ordered the withdrawal of Cannabiron CBD and Good Cannabis creams from the market, as they contain...
The Portuguese pharmaceutical company Biojam announced that it intends to place a product on the Portuguese market, but that it has not yet managed to do so because Infarmed has been for at least...
